Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oxford BioMedica ( (GB:OXB) ) has provided an announcement.
Oxford Biomedica PLC announced a significant change in its shareholder structure as M&G Plc has reduced its voting rights from 9.92% to 4.878%. This adjustment in holdings indicates a shift in investment strategy by M&G Plc, potentially impacting Oxford Biomedica’s market positioning and shareholder dynamics.
More about Oxford BioMedica
Oxford Biomedica PLC operates within the biotechnology sector, specializing in the development of gene and cell therapy products. It focuses on providing innovative solutions for advancing gene and cell therapies, particularly within the UK market.
YTD Price Performance: -6.91%
Average Trading Volume: 1,739
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $506.7M
Find detailed analytics on OXB stock on TipRanks’ Stock Analysis page.